Supportive therapy for primary infection, Acyclovir for treating severe systemic infections, or to reduce the duration of the recurrent infections, Acyclovir activated by thymidine kinase (produced by herpes viruses), therefore it inhibits DNA polymerase in infected cells and not in healthy cells, Topical: 5% Acyclovir 5 times/day, Systemic: 200-400 mg 5 times per day (immune compromised), should be used as early as possible